Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Smith & Nephew (SNN) Non-Current Assets (2009 - 2025)

Smith & Nephew (SNN) posted Non-Current Assets of $6.4 billion for Q4 2025, up 7.1% on a QoQ basis from $5.9 billion in Q4 2024, and up 7.1% year-over-year from $5.9 billion in Q4 2024.

Smith & Nephew (SNN) has 10 years of Non-Current Assets data on file, last reported at $6.4 billion in Q4 2025.

  • In Q4 2025, Non-Current Assets rose 7.1% year-over-year to $6.4 billion; the TTM figure through Dec 2025 stood at $6.4 billion (up 7.1% YoY), while the FY2025 annual figure was $6.4 billion, up 7.1% from the prior year.
  • Non-Current Assets advanced to $6.4 billion in Q4 2025, from $5.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $6.5 billion in Q4 2021 and bottomed at $5.9 billion in Q4 2024.
  • A 5-year average of $6.2 billion and a median of $6.1 billion in 2022 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets decreased 5.94% — and 2025, when it rose 7.1%.
  • Year by year, Non-Current Assets stood at $6.5 billion in 2021, then retreated by 5.94% to $6.1 billion in 2022, then retreated by 2.5% to $6.0 billion in 2023, then declined by 0.4% to $5.9 billion in 2024, then increased by 7.1% to $6.4 billion in 2025.
  • The last three Non-Current Assets figures came in at $6.4 billion (Q4 2025), $5.9 billion (Q4 2024), and $6.0 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 84.92 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 32.95 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 67.41 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 35.67 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 7.09 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.47 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.30 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 26.70 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.34 Bn
10 Smith & Nephew 5.16 Bn 4.58 Bn - 6.35 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 6.35 Bn
Dec 31, 2024 5.93 Bn
Dec 31, 2023 5.96 Bn
Dec 31, 2022 6.11 Bn
Dec 31, 2021 6.50 Bn
Dec 31, 2020 6.35 Bn
Dec 31, 2019 6.08 Bn
Dec 31, 2018 4.98 Bn
Dec 31, 2017 5.14 Bn
Dec 31, 2016 4.82 Bn
Dec 31, 2015 4.69 Bn
Jun 30, 2015 4.78 Bn
Dec 31, 2014 4.87 Bn
Jun 28, 2014 5.21 Bn
Mar 31, 2014 3.55 Bn
Dec 31, 2013 3.56 Bn
Sep 28, 2013 3.40 Bn
Mar 31, 2013 3.40 Bn
Dec 31, 2012 3.50 Bn
Sep 29, 2012 2.71 Bn
Mar 31, 2012 2.69 Bn
Dec 31, 2011 2.54 Bn
Dec 31, 2010 2.58 Bn
Dec 31, 2009 2.48 Bn